PRESS RELEASE published on 05/23/2024 at 14:30, 1 year 11 months ago Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product Jaguar Health, Inc. announces commercial launch at ASCO Annual Meeting for Gelclair, FDA-approved oral mucositis product. Focus on cancer supportive care with phase 3 OnTarget trial results impending Jaguar Health Phase 3 Trial Gelclair Oral Mucositis ASCO Annual Meeting
BRIEF published on 05/17/2024 at 22:20, 1 year 11 months ago Jaguar Health, Inc. Announces Reverse Stock Split Jaguar Health Inc Reverse Stock Split Nasdaq Compliance Institutional Investors Stock Adjustment
BRIEF published on 05/17/2024 at 22:20, 1 year 11 months ago Jaguar Health, Inc. annonce un regroupement d'actions Investisseurs Institutionnels Conformité NASDAQ Ajustement Des Stocks Regroupement Inversé Des Actions Jaguar Santé Inc.
PRESS RELEASE published on 05/17/2024 at 22:15, 1 year 11 months ago Jaguar Health, Inc. Announces Reverse Stock Split Jaguar Health announces reverse split approval at Special Meeting of Stockholders to boost Nasdaq compliance. Stock trading on split-adjusted basis from May 23, 2024. Details in SEC filing Stockholders Meeting Jaguar Health Nasdaq Compliance Reverse Split SEC Filing
BRIEF published on 05/14/2024 at 14:05, 1 year 11 months ago Jaguar Health Reports First Quarter 2024 Financial Results Financial Results Crofelemer Jaguar Health Q1 2024 Gelclair
BRIEF published on 05/14/2024 at 14:05, 1 year 11 months ago Jaguar Health publie ses résultats financiers du premier trimestre 2024 Résultats Financiers Crofelemer Santé Jaguar T1 2024 Gelclair
PRESS RELEASE published on 05/14/2024 at 14:00, 1 year 11 months ago Jaguar Health Reports First Quarter 2024 Financial Results Jaguar Health, Inc. reports Q1 2024 financial results, with revenue increasing 20% over Q1 2023. Key updates include OnTarget trial progress and Gelclair® commercial launch plans Financial Results Jaguar Health Q1 2024 OnTarget Trial Gelclair
BRIEF published on 05/13/2024 at 18:40, 1 year 11 months ago Jaguar Health, Inc. Announces Q1 2024 Webcast to Discuss Financials and Corporate Updates Earnings Report Jaguar Health Q1 2024 Financial Webcast Corporate Updates
BRIEF published on 05/13/2024 at 18:40, 1 year 11 months ago Jaguar Health, Inc. annonce une webdiffusion du premier trimestre 2024 pour discuter des données financières et des mises à jour de l'entreprise Rapport Sur Les Revenus Santé Jaguar T1 2024 Webdiffusion Financière Mises À Jour De L'entreprise
PRESS RELEASE published on 05/13/2024 at 18:35, 1 year 11 months ago REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates Jaguar Health, Inc. to conduct investor webcast on May 14, 2024 at 8:30 a.m. Eastern to review first-quarter 2024 financials and provide corporate updates. Company plans to file its Earnings Report on the same day Investor Webcast Form 10-Q Jaguar Health Inc. Corporate Updates First-quarter Financials
Published on 05/09/2026 at 01:30, 1 day 20 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 22 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 6 hours 20 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 8 hours 25 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 10 hours 40 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 3 hours ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days 1 hour ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 3 days 3 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 3 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 3 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 3 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 3 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL